These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23121727)

  • 21. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis.
    Frisoni GB; Pizzolato G; Zanetti O; Bianchetti A; Chierichetti F; Trabucchi M
    Eur Neurol; 1995; 35(1):50-4. PubMed ID: 7737248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.
    Meyer PT; Sattler B; Winz OH; Fundke R; Oehlwein C; Kendziorra K; Hesse S; Schaefer WM; Sabri O
    Neuroimage; 2008 Aug; 42(2):548-58. PubMed ID: 18595739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Zwanzger P; Mulert C; Rupprecht R; Möller HJ; Hegerl U; Padberg F
    J Psychiatr Res; 2006 Jun; 40(4):307-14. PubMed ID: 16259998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography.
    Lobbezoo F; Soucy JP; Montplaisir JY; Lavigne GJ
    J Dent Res; 1996 Oct; 75(10):1804-10. PubMed ID: 8955676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".
    Koga S; Roemer SF; Kasanuki K; Dickson DW
    Parkinsonism Relat Disord; 2019 Nov; 68():79-84. PubMed ID: 31621626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A; Westera G; Sutter M; Albani C; Kung HF; vonSchulthess GK
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.
    Yeh TL; Yang YK; Chiu NT; Yao WJ; Yeh SJ; Wu JS; Chuang JI; Chang SH
    Am J Hypertens; 2006 Sep; 19(9):964-9. PubMed ID: 16942941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An autopsy case of corticobasal degeneration with inferior olivary hypertrophy.
    Ishida C; Kato-Motozaki Y; Noto D; Komai K; Hasegawa M; Ikeuchi T; Yamada M
    Neuropathology; 2021 Jun; 41(3):226-235. PubMed ID: 33847035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
    Oertel WH; Tatsch K; Schwarz J; Kraft E; Trenkwalder C; Scherer J; Weinzierl M; Vogl T; Kirsch CM
    Ann Neurol; 1992 Dec; 32(6):743-8. PubMed ID: 1471864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].
    Hierholzer J; Cordes M; Schelosky L; Sander B; Böck JC; David I; Horowski R; Poewe W
    Rofo; 1993 Jul; 159(1):86-90. PubMed ID: 8334264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R
    Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study.
    Boeve BF
    J Mol Neurosci; 2011 Nov; 45(3):350-3. PubMed ID: 21853287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.
    Hossain AK; Murata Y; Zhang L; Taura S; Saitoh Y; Mizusawa H; Oda K; Matsushima E; Okubo Y; Shibuya H
    Mov Disord; 2003 Jun; 18(6):697-703. PubMed ID: 12784276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticobasal degeneration initially developing motor versus non-motor symptoms: a comparative clinicopathological study.
    Ikeda C; Yokota O; Nagao S; Ishizu H; Morisada Y; Terada S; Nakashima Y; Akiyama H; Uchitomi Y
    Psychogeriatrics; 2014 Sep; 14(3):152-64. PubMed ID: 25186621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.